title: Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment.
authors.affiliation: Institute of Infectious Diseases, University of Catania, Italy.
authors.forename: B
authors.initials: B
authors.lastname: Cacopardo
authors.forename: L
authors.initials: L
authors.lastname: Nigro
authors.forename: W
authors.initials: W
authors.lastname: Preiser
authors.forename: A
authors.initials: A
authors.lastname: Famá
authors.forename: M I
authors.initials: MI
authors.lastname: Satariano
authors.forename: J
authors.initials: J
authors.lastname: Braner
authors.forename: B M
authors.initials: BM
authors.lastname: Celesia
authors.forename: B
authors.initials: B
authors.lastname: Weber
authors.forename: R
authors.initials: R
authors.lastname: Russo
authors.forename: H W
authors.initials: HW
authors.lastname: Doerr
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000150:complications / Q000276:immunology*; D000328:Adult; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D016207:Cytokines / Q000378:metabolism; D004797:Enzyme-Linked Immunosorbent Assay; D005260:Female; D015497:HIV-1 / Q000502:physiology; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000150:complications / Q000188:drug therapy / Q000276:immunology*; D008213:Lymphocyte Activation; D008297:Male; D008536:Meglumine / Q000627:therapeutic use; D000077485:Meglumine Antimoniate; D009942:Organometallic Compounds / Q000627:therapeutic use; D012367:RNA, Viral / Q000378:metabolism; D013601:T-Lymphocytes / Q000276:immunology; D018418:Th2 Cells / Q000276:immunology*; D014779:Virus Replication
chemical_list: D000981:Antiprotozoal Agents; D016207:Cytokines; D009942:Organometallic Compounds; D012367:RNA, Viral; D008536:Meglumine; D000077485:Meglumine Antimoniate